Ex Vivo Human Thrombosis Chamber Study

• Status: Completed
• Trial end date: 2009-10-01
• Target enrollment: 0
• Participant gender: Male

Summary

Purpose of study is to evaluate a thrombosis chamber model

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Bristol-Myers Squibb
• Treatments: Aspirin; Clopidogrel

Criteria

Inclusion Criteria:

• Healthy Subjects

• BMI 18-30 kg/m²

• Male ages 18-45

Exclusion Criteria:

• Significant acute or chronic illness

• History of abnormal bleeding or coagulation disorder, intracranial hemorrhage, or a family history of abnormal bleeding or coagulation disorder in a first degree relative under 50 years of age

• Easy bruising

• Smoking within 3 months prior to Day 1